Roche Holding AG (Jobs) Says Tamiflu Capacity Outstrips Demand
BASEL, Switzerland (Reuters) - Swiss-based pharmaceutical group Roche on Thursday said the company and its partners had increased production capacity for influenza drug Tamiflu to more than 400 million treatments a year.
Supply now significantly exceeds current Tamiflu orders and the company said it was cutting production so it meets current demand.